Loading...
SITCSection 5
U.S. imports of penicillin & streptomycin medicaments, dosage form or retail packings (SITC 54213) totaled $30.6M in April 2026, traded with 15 countries.
Last updated: April 2026 dataFinished antibiotic medicaments containing penicillins, streptomycins, or their derivatives — put up in measured doses or retail-ready packaging — are among the most widely traded pharmaceutical finished goods in global commerce. FDA requires that all imported finished drug products be manufactured in registered foreign establishments and comply with cGMP; shipments may be subject to import alerts if the manufacturer has a compliance history. The dosage-form distinction is commercially significant because these products are ready for dispensing or sale, commanding different duty treatment and supply-chain handling than their bulk counterparts. Amoxicillin tablets, ampicillin capsules, and streptomycin vials are representative examples within this heading.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
FDA expects the foreign manufacturer to be registered in the FDA Drug Establishment Registration system and the specific drug product to be listed. Entry documentation should support the product's identity, strength, and labeling compliance. Shipments may be subject to examination or sampling, and products from establishments under import alert face automatic detention without physical examination.
No — the heading explicitly covers penicillins, streptomycins, and their derivatives in dosage form, so semi-synthetic penicillins such as amoxicillin, ampicillin, and oxacillin all fall within this category. The key classification test is whether the active ingredient is a penicillin or streptomycin derivative, not whether it is the natural compound.
Supplier Network
Get discovered by U.S. importers searching for HS 54213 — Penicillin & Streptomycin Medicaments, Dosage Form or Retail Packings. Be the first supplier listed.
Monthly import values over time